Pharmacists in Smoking Cessation
IPU-Review-FEBRUARY-2017
IPU-Review-FEBRUARY-2017
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MINI<br />
3<br />
*<br />
MINUTES<br />
START TO RELIEVE CRAVINGS IN JUST<br />
*4mg lozenge vs. placebo<br />
START<br />
TO RELIEVE<br />
CRAVINGS<br />
IN JUST<br />
m<strong>in</strong>utes *<br />
*4mg lozenge vs. placebo<br />
M<strong>in</strong>i Lozenges:<br />
Starts to relieve<br />
sudden crav<strong>in</strong>gs fast *<br />
Patch:<br />
Smart control technology<br />
for 24 hour crav<strong>in</strong>g control<br />
*4mg only<br />
Product Information: NiQuit<strong>in</strong> M<strong>in</strong>i 4 mg M<strong>in</strong>t Lozenges (nicot<strong>in</strong>e) and NiQuit<strong>in</strong> Clear 21mg/24hrs transdermal patches (nicot<strong>in</strong>e). Indications: Treatment of<br />
tobacco dependence by relief of nicot<strong>in</strong>e withdrawal symptoms and crav<strong>in</strong>gs. Use with behavioural support. Legal category: GSL. PA 1186/18/12 and PA 1186/18/3.<br />
Licence Holder: Chefaro Ireland Ltd. First Floor, Block A, The Crescent Build<strong>in</strong>g, Northwood Office Park, Dubl<strong>in</strong> 9, Ireland. Information about this product, <strong>in</strong>clud<strong>in</strong>g adverse<br />
reactions, precautions, contra-<strong>in</strong>dications and method of use can be found at: http://www.medic<strong>in</strong>es.ie/medic<strong>in</strong>e/14492/SPC/NiQuit<strong>in</strong>+M<strong>in</strong>i+4mg+m<strong>in</strong>t+lozenges/ and<br />
http://www.medic<strong>in</strong>es.ie/medic<strong>in</strong>e/12138/SPC/NiQuit<strong>in</strong>+CLEAR+21+mg+24+hours+transdermal+patch/ Date of revision: August 2016.